1. Home
  2. MFIN vs CNTN Comparison

MFIN vs CNTN Comparison

Compare MFIN & CNTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Medallion Financial Corp.

MFIN

Medallion Financial Corp.

HOLD

Current Price

$10.94

Market Cap

229.0M

Sector

Finance

ML Signal

HOLD

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$1.86

Market Cap

185.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MFIN
CNTN
Founded
1995
2017
Country
United States
United States
Employees
179
12
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
229.0M
185.3M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
MFIN
CNTN
Price
$10.94
$1.86
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
40.4K
757.7K
Earning Date
04-29-2026
05-13-2026
Dividend Yield
5.18%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.02
N/A
P/E Ratio
$6.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.85
$1.75
52 Week High
$11.05
$5.27

Technical Indicators

Market Signals
Indicator
MFIN
CNTN
Relative Strength Index (RSI) 67.98 35.03
Support Level $9.20 N/A
Resistance Level N/A $3.80
Average True Range (ATR) 0.32 0.17
MACD 0.11 0.01
Stochastic Oscillator 87.19 18.97

Price Performance

Historical Comparison
MFIN
CNTN

About MFIN Medallion Financial Corp.

Medallion Financial Corp is a finance company that originates and services loans in various industries. The four operating segments are, (1) recreation, (2) home improvement, (3) commercial and (4) taxi medallion The company generates maximum revenue from the Recreation segment. The company's geographic Concentrations are in united states diversified in California, Wisconsin, New York, Texas and others.

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

Share on Social Networks: